Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenter phase II study

INTRODUCTION: A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated administration of a bupivacaine lozenge (25 mg) as pain management for oral mucositis pain in head and neck cancer patients as add-on to standard systemic pain management. OBJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mogensen, Stine, Treldal, Charlotte, Kristensen, Claus A., Bentzen, Jens, Lawson-Smith, Louise, Petersen, Janne, Andersen, Ove
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2017
Materias:
Cancer and Palliative
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777682/
https://www.ncbi.nlm.nih.gov/pubmed/29392234
http://dx.doi.org/10.1097/PR9.0000000000000619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777682/
https://www.ncbi.nlm.nih.gov/pubmed/29392234
http://dx.doi.org/10.1097/PR9.0000000000000619

Ejemplares similares